TherapeuticsMD
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $869 | $724 | $893 | $784 |
Gross Profit | 869 | 724 | 893 | 784 |
EBITDA | 164 | -629 | -3,242 | 149 |
EBIT | -723 | -4,148 | 53 | |
Net Income | 155 | 95 | -619 | 152 |
Net Change In Cash | 869 | 724 | 893 | 784 |
Free Cash Flow | 770 | 936 | 368 | 1,046 |
Cash | 9,189 | 8,419 | 7,483 | 7,115 |
Basic Shares | 11 | 11,640 | 11,569 | 11,574 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,022 | $1,761 | $1,302 | $69,963 |
Gross Profit | 3,022 | 1,761 | 1,302 | 68,566 |
EBITDA | -3,021 | -3,564 | -7,601 | 11,863 |
EBIT | -4,214 | -4,844 | -8,523 | 10,663 |
Net Income | -569 | -2,181 | -10,278 | 111,997 |
Net Change In Cash | 3,022 | 1,761 | 1,302 | 69,963 |
Free Cash Flow | 2,424 | 732 | -48,141 | -4,433 |
Cash | 7,483 | 5,059 | 4,327 | 38,067 |
Basic Shares | 11,569 | 11,532 | 10,441 | 9,028 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.01 |
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | $0 |